Valerie Rodriguez-garcia

Array ( [id] => 6189999 [patent_doc_number] => 20110172283 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-14 [patent_title] => 'Tricyclic Indeno-Pyrrole Derivatives as Serotonin Receptor Modulators' [patent_app_type] => utility [patent_app_number] => 13/071732 [patent_app_country] => US [patent_app_date] => 2011-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29313 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0172/20110172283.pdf [firstpage_image] =>[orig_patent_app_number] => 13071732 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10169259 [patent_doc_number] => 09199961 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-12-01 [patent_title] => 'Preparation of caprolactone, caprolactam, 2,5-tetrahydrofuran-dimethanol, 1,6-hexanediol or 1,2,6-hexanetriol from 5-hydroxymethyl-2-furfuraldehyde' [patent_app_type] => utility [patent_app_number] => 13/699934 [patent_app_country] => US [patent_app_date] => 2011-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8766 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13699934 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9321626 [patent_doc_number] => 08656638 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-02-25 [patent_title] => 'Compounds and processes that generate cyclopropenes and substituted cyclopropenes on demand' [patent_app_type] => utility [patent_app_number] => 13/065521 [patent_app_country] => US [patent_app_date] => 2011-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 5807 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13065521 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6101696 [patent_doc_number] => 20110165188 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-07 [patent_title] => 'N-HYDROXYAMIDINOHETEROCYCLES AS MODULATORS OF INDOLEAMINE 2,3-DIOXYGENASE' [patent_app_type] => utility [patent_app_number] => 13/050143 [patent_app_country] => US [patent_app_date] => 2011-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28792 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0165/20110165188.pdf [firstpage_image] =>[orig_patent_app_number] => 13050143 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6101696 [patent_doc_number] => 20110165188 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-07 [patent_title] => 'N-HYDROXYAMIDINOHETEROCYCLES AS MODULATORS OF INDOLEAMINE 2,3-DIOXYGENASE' [patent_app_type] => utility [patent_app_number] => 13/050143 [patent_app_country] => US [patent_app_date] => 2011-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28792 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0165/20110165188.pdf [firstpage_image] =>[orig_patent_app_number] => 13050143 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7733724 [patent_doc_number] => 20120016019 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-19 [patent_title] => 'PHARMACEUTICAL COMPOSITION FOR TREATING OR PREVENTING CANCER' [patent_app_type] => utility [patent_app_number] => 13/043672 [patent_app_country] => US [patent_app_date] => 2011-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 45 [patent_figures_cnt] => 45 [patent_no_of_words] => 19519 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0016/20120016019.pdf [firstpage_image] =>[orig_patent_app_number] => 13043672 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6163172 [patent_doc_number] => 20110160192 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-30 [patent_title] => 'BIARYL AMINO ACIDS AND THEIR USE IN DNA BINDING OLIGOMERS' [patent_app_type] => utility [patent_app_number] => 13/041849 [patent_app_country] => US [patent_app_date] => 2011-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 24849 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20110160192.pdf [firstpage_image] =>[orig_patent_app_number] => 13041849 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8618375 [patent_doc_number] => 20130023687 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-01-24 [patent_title] => 'SURFACTANT FOR STABILIZING WATER/SUPERCRITICAL CARBON DIOXIDE MICROEMULSION' [patent_app_type] => utility [patent_app_number] => 13/582580 [patent_app_country] => US [patent_app_date] => 2011-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 5089 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13582580 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7742150 [patent_doc_number] => 20120020915 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-26 [patent_title] => 'Compounds and Methods for Treating Cancer and Diseases of the Central Nervous System' [patent_app_type] => utility [patent_app_number] => 13/006338 [patent_app_country] => US [patent_app_date] => 2011-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 37 [patent_no_of_words] => 55954 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0020/20120020915.pdf [firstpage_image] =>[orig_patent_app_number] => 13006338 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7762891 [patent_doc_number] => 08115009 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-02-14 [patent_title] => 'UV-absorbers for ophthalmic lens materials' [patent_app_type] => utility [patent_app_number] => 13/004373 [patent_app_country] => US [patent_app_date] => 2011-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2648 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/115/08115009.pdf [firstpage_image] =>[orig_patent_app_number] => 13004373 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8028445 [patent_doc_number] => 08143306 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-03-27 [patent_title] => 'Methods of treating bipolar disorders' [patent_app_type] => utility [patent_app_number] => 12/984318 [patent_app_country] => US [patent_app_date] => 2011-01-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16235 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/143/08143306.pdf [firstpage_image] =>[orig_patent_app_number] => 12984318 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10057255 [patent_doc_number] => 09096601 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-08-04 [patent_title] => 'Arylamino purine derivatives, preparation method and pharmaceutical use thereof' [patent_app_type] => utility [patent_app_number] => 13/699960 [patent_app_country] => US [patent_app_date] => 2010-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 33707 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13699960 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9099736 [patent_doc_number] => 08563614 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-10-22 [patent_title] => 'Use of treprostinil to treat neuropathic diabetic foot ulcers' [patent_app_type] => utility [patent_app_number] => 12/926945 [patent_app_country] => US [patent_app_date] => 2010-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4562 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12926945 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9099736 [patent_doc_number] => 08563614 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-10-22 [patent_title] => 'Use of treprostinil to treat neuropathic diabetic foot ulcers' [patent_app_type] => utility [patent_app_number] => 12/926945 [patent_app_country] => US [patent_app_date] => 2010-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4562 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12926945 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9469271 [patent_doc_number] => 08722902 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-05-13 [patent_title] => '1,3-diiodohydantoin compound and production method thereof' [patent_app_type] => utility [patent_app_number] => 12/926898 [patent_app_country] => US [patent_app_date] => 2010-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5954 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12926898 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6085049 [patent_doc_number] => 20110144350 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-16 [patent_title] => '1,3-Diiodohydantoin compound and production method thereof' [patent_app_type] => utility [patent_app_number] => 12/926899 [patent_app_country] => US [patent_app_date] => 2010-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5952 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0144/20110144350.pdf [firstpage_image] =>[orig_patent_app_number] => 12926899 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9582502 [patent_doc_number] => 08772506 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-07-08 [patent_title] => '1,3-diiodohydantoin compound and production method thereof' [patent_app_type] => utility [patent_app_number] => 12/926900 [patent_app_country] => US [patent_app_date] => 2010-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5956 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 115 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12926900 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9153708 [patent_doc_number] => 08586614 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-11-19 [patent_title] => 'Urea glucokinase activators' [patent_app_type] => utility [patent_app_number] => 12/961867 [patent_app_country] => US [patent_app_date] => 2010-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 64689 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12961867 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10063771 [patent_doc_number] => 09102602 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-08-11 [patent_title] => 'Method for producing isothiocyanate compound' [patent_app_type] => utility [patent_app_number] => 13/990312 [patent_app_country] => US [patent_app_date] => 2010-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5342 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13990312 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6203145 [patent_doc_number] => 20110065931 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-17 [patent_title] => 'ATORVASTATIN CALCIUM PROPYLENE GLYCOL SOLVATES' [patent_app_type] => utility [patent_app_number] => 12/946183 [patent_app_country] => US [patent_app_date] => 2010-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 4144 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0065/20110065931.pdf [firstpage_image] =>[orig_patent_app_number] => 12946183 [rel_patent_id] =>[rel_patent_doc_number] =>)